Registered entities
Kura Oncology, Inc.
Reg. No. 32084798068United States
Kura Oncology, Inc.
Reg. No. 611547851United States
Innovation
65 patent families (21 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 8,559 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 10 |
| 2018 | 18 |
| 2019 | 18 |
| 2020 | 24 |
| 2021 | 23 |
| 2022 | 16 |
| 2023 | 20 |
| 2024 | 19 |
| 2025 | 22 |
| 2026 | 6 |
Social engagement
Social engagement: 36.8K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include EcoR1; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 42% |
| Private equity | 3 | 25% |
| Other / undisclosed | 4 | 33% |
Hiring activity
Hires periodically
3 roles tracked across 3 of the last 12 months
31 Mar 2026 · Director, Supply Chain · Boston
12 Nov 2025 · AD/Director, Clinical Data Sciences · Boston
12 Sep 2025 · Manager/Senior Manager, Clinical Data Sciences · Boston
11 Sep 2025 · Associate Director/Director, Clinical Pharmacology · Boston
23 Aug 2025 · Senior Clinical Trial Leader · Boston
Based on job postings tracked across public sources.
Recent activity
23 Jun 2026
Event
BIOC International Convention discussion on oncology investment trends
16 Jun 2026
Recognition
12 Jun 2026
Event
2026 EHA Congress